Lecture 28 - Novel Analgesics II Flashcards

1
Q

Type of receptor that CB1 is

A

GPCR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Where is CB1R found?

A

Brain, spinal cord, peripheral nerves, fat, muscle, liver

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Where is CB2R expressed?

A

Non-neural tissues, especially microglia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Name for cannabinoids derived from cannabis plants

A

Phytocannabinoids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Brain distribution of CB1R
1)
2)
3)

A

1) Dense in hypothalamus, cortex, hippocampus, cerebellum
2) Low density in brainstem
3) Present in pain pathways of brain and spinal cord

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q
Effects of cannabinoid agonists
1)
2)
3)
4)
5)
6)
A

1) Analgesia
2) Motor coordination impairment
3) Memory disruption
4) Anti-emesis
5) Anxiolysis
6) Cardiovascular effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Parts of pain pathways that endocannabinoids modulate
1)
2)
3)

A

1) Primary sensory afferents - CB1 agonists inhibit
2) Dorsal horn - CB1 agonists inhibit activity of relay neurons
3) Descending modulatory control pathway (inhibitory pathway) - CB1 agonists enhance activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How do CB1 agonists inhibit activity of dorsal horn relay neurons involved in ascending pain pathway?
1)
2)

A

1) Interaction with N-type calcium channels leads to decreased calcium entry into neuron. Reduced neurotransmitter release
2) Activates potassium channels on post-synaptic neurons, hyperpolarises them.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How do CB1 agonists enhance activity of inhibitory descending pain modulatory pathways?

A

Via alpha2 adrenoceptor pathways

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Examples of endogenous CB1 agonists
1)
2)

A

1) Anandamide

2) 2-arachidonylglycerol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Examples of synthetic cannabinoid agonists
1)
2)

A

1) CP55,940

2) Nabilone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Sativex

A

1) Oralmucosal spray

2) Combination

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

THC effects

A

Analgesic, muscle relaxant, antiemetic, appetite stimulant, psychoactive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Cannabidiol effects

A

Analgesic, anticonvulsant, muscle relaxant, anxiolytic, antioxidant, antipsychotic, neuroprotective

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What can Sativex be used for?

A

Adjunctive treatment for symptomatic relief of pain in MS, neuropathic cancer-related pain, AIDS neuropathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How is Sativex administered?

A

Oralmucosal spray

Self-titrated, as THC and CBD doses are highly variable

17
Q

Sativex efficacy

A

41% improvement over baseline, 20% improvement over placebo

18
Q

Common underlying mechanism of neuropathic pain

A

Inflammation at site of damaged nerve

19
Q

Normal response to nerve injury
1)
2)

A

1) Nerve injury provokes recruitment, activation of immune cells at site of injury, dorsal root ganglia, ventral, dorsal spinal cord horns
2) Macrophages, T lymphocytes, mast cells cluster around distal stumps of nerve to guide neuronal regeneration

20
Q
Neuropathic response to nerve injury
1)
2)
3)
4)
5)
A

1) Peripheral nerve injury.
2) Synaptic projection of a pain-sensing neuron in the spinal cord releases ATP
3) Nearby microglia are drawn to ATP, activated
4) Fully activated microglia localise around pain-sensing neuron, release neuroinflammatory agents
5) These agents lead to increased calcium, chlorine ions in the neuron, depolarising it, leading to sensitisation

21
Q
How does ATP activate microglia?
1)
2)
3)
4)
A

1) Binds P2X4R on microglial surface.
2) This leads to increased intracellular calcium levels
3) This leads to NF-kB translocation to nucleus, p38 MAPK pathway stimulation.
4) This leads to increased transcription of neuroinflammatory agents

22
Q

Cells that are activated in pain state, and can lead to neuropathic pain conditions

A

Microglia, astrocytes

23
Q

Astrocyte response to pain state
1)
2)
3)

A

1) Pro-inflammatory cytokines activate astrocytes
2) Activated astrocytes undergo hypertrophy, release neuroinflammatory agents.
3) Neuroinflammatory agents depolarise neurons, leading to sensitisation

24
Q

Cannabinoid receptor particularly expressed by glial cells

A

CB2R

25
Q

When is CB2R upregulated in the brain?

A

In response to infection, inflammation or tissue injury

26
Q
Cannabinoid effects on neuroinflammation 
1)
2)
3)
4)
A

1) Inhibit immune cell entry into the brain
2) CB1R agonists prevent excitotoxicity by reducing glutamate release
3) CB2R agonists reduce glial release of pro-inflammatory molecules and promote glial release of anti-inflammatory molecules
4) Cannabinoids are anti-oxidants, and reduce toxicity of ROS

27
Q

CB2 potential roles

A

1) MS-related pain and mobility
2) Chemotherapy-induced peripheral neuropathy
3) Neuropathic pain
4) Increased efficacy of opioids

28
Q

Why do CB2 agonists increase opioid efficacy?

A

Glial activation opposes opioid analgesia, enhances opioid tolerance and dependence.
CB2 agonists reduce release of glial pro-inflammatory agents

29
Q

Example of drugs with a synergistic effect

A

CP55,940 and morphine

30
Q

Example of an alpha2 adrenoceptor agonist

A

Dexmedetomidine

31
Q
Role of alpha2 adrenoceptor agonists
1)
2)
3)
4)
A

1) Weak antinociceptive efficacy in acute pain
2) Located in dorsal horn of spinal cord
3) Associated with N-type voltage-gated calcium channels
4) Role in neuropathic pain

32
Q

How can it be tested whether a drug combination acts additively or synergistically?

A

Isobologram

33
Q

How is an isobologram constructed?

A

On each axis place ED50 of a drug, draw a line between them.
If a drug combination acts additively, ED50 will be on this line.
If acts synergistically, ED50 will be closer to zero.

34
Q

Example of a thermal nociception test that tests supraspinal nociception

A

Heat plate test

35
Q

Example of a thermal nociception test that tests spinal reflex nociception

A

Tail flick test